THE THERAPEUTIC EFFECTS OF SHENMAI ON BRADYCARDIA ARRHYTHIMA IN PATIENTS WITH CORONARY HEART DISEASE.
Yalin Liu
Abstract
Yalin Liu
Abstract
Objective:To observe therapeutic effect of Shenmai on bradycardia arrhythima in patients with coronary heart disease.Methods:The treatment group's patients were 118,with shenmai injection 40 ml+5%G.S 250 ml IV drip,patients with cardiac infarcation from first day to third day(24 h continuous use);Control groups:patients was 112 with frequent treatment(nitriteasprit).Result:The effective rate was 83.56% in the treatment group,51.25% in the control group,there were significantly different between them(P0.05).Conclusion:It suggests that Shenmai can significantly treat bradycardia arrhythima patients with coronary heart disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe therapeutic effect of Shenmai on bradycardia arrhythima in patients with coronary heart disease.Methods:The treatment group's patients were 118,with shenmai injection 40 ml+5%G.S 250 ml IV drip,patients with cardiac infarcation from first day to third day(24 h continuous use);Control groups:patients was 112 with frequent treatment(nitriteasprit).Result:The effective rate was 83.56% in the treatment group,51.25% in the control group,there were significantly different between them(P0.05).Conclusion:It suggests that Shenmai can significantly treat bradycardia arrhythima patients with coronary heart disease.
Key concepts: Bradycardia, Medicine, Coronary heart disease, Therapeutic effect, Cardiology, Internal medicine, Heart rate, Anesthesia